Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Transchem Ltd (TRANSCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500422 NSE: TRANSCHEM Trading | Small Cap | Transchem Share Price

₹319 11.75 (3.82%)

As on 14-Aug'26 16:59

Transchem Ltd (TRANSCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500422 NSE: TRANSCHEM Trading | Small Cap | Transchem Share Price

₹319 11.75 (3.82%)

As on 14-Aug'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹390 Cr.
Current Price
₹319
52-Week Low / High
₹38 / 378
TTM EPS
₹5.5
TTM Sales
₹0 Cr.
Book Value per Share
₹71.1
P/E Ratio
58.07
Higher than its 5-year historical median
Industry PE
39.6
Price to Book (P/B)
4.49
Higher than its 5-year historical median
Price to Sales (P/S)
0.00
Lower than its 3-year historical median
EV/EBITDA
40.10
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
5.27%
Outperforms industry median
Return on Capital Employed (ROCE)
6.89%
Outperforms industry median
Return on Assets (ROA)
5.14%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-17.78%
Asset Quality
Promoter Holding
56.45%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹75 Cr.
Equity
₹12.2 Cr.
Face Value
₹10
All Time Low / High
₹2.55 / 377.65

Transchem stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Transchem Ltd a good quality company?
Transchem Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Transchem Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Transchem Ltd vs industry peers?
Transchem Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.54%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Transchem Ltd?
Promoters hold 56.45% of the Transchem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Transchem Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 34.1% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transchem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ-0.6%-1.5%2.1%2.1%49.7%6.1%3.8%8%9.1%6.9%-
Value Creation
Index ⓘ		-1.0-1.1-0.9-0.92.6-0.6-0.7-0.4-0.4-0.5-

Growth Parameters ⓘ
Sales ⓘ000022.5000.42.600
Sales YoY Gr.-NANANANA-100%NANA541.5%-100%-
Adj EPS ⓘ-1.1-1.50.10.319.72.313.442.65.5
YoY Gr.-NANA135.7%5878.8%-88.1%-56.8%239.6%16.3%-34.3%-
BVPS (₹) ⓘ3130.1313051.454.253.861.864.868.371.1
Adj Net
Profit ⓘ		-1.3-1.80.20.424.22.91.24.24.93.27
Cash Flow from Ops. ⓘ0.6-19.810.3-0.6-27.721.91.2-39.336-1.6-
Debt/CF from Ops. ⓘ0000000000-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNA-100%NA-100%
Adj EPS ⓘNA-33.2%37.4%-34.3%
BVPSⓘ9.2%5.8%8.3%5.4%
Share Price 34.1% 65.2% 138.8% 705.8%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ		-3.4-4.90.41.148.54.41.95.96.33.97.9
Op. Profit
Mgn % ⓘ		000091.400-423.4-55.70NAN
Net Profit
Mgn % ⓘ		0000107.5001025.2185.50INF
Debt to
Equity ⓘ		0000000000-
Working Cap
Days ⓘ		00004570040,2467,09900
Cash Conv.
Cycle ⓘ		000010018320900

Valuation of Transchem - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales00002200030
Operating Expenses ⓘ + 1211232244
Manufacturing Costs0000000000
Material Costs0000000030
Employee Cost 0001111111
Other Costs ⓘ 1111121113
Operating Profit ⓘ -1-2-1-121-3-2-2-1-4
Operating Profit Margin (%) ----91.4%---423.0%-55.7%-
Other Income ⓘ + 2233474799
Exceptional Items ⓘ 0000000000
Interest ⓘ 0000000000
Depreciation ⓘ 1111000000
Profit Before Tax ⓘ -0-1112543676
Tax ⓘ 0100111121
Profit After Tax -0-1002431454
PAT Margin (%) ----107.5%--1,025.2%198.7%-
Adjusted EPS (₹)-0.2-1.00.30.319.72.31.03.44.33.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 38373837636666767984
Share Capital ⓘ 12121212121212121212
Reserves ⓘ 26252625515454636771
Debt +0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables0000000000
Others Liabilities ⓘ -0000010104
Total Liabilities ⓘ 38373837636766768088

Fixed Assets

Net Fixed Assets ⓘ +6544000000
Gross Block7766000000
Accumulated Depreciation1222000000
CWIP ⓘ 0000000000
Investments ⓘ 301064998922
Inventories1000000000
Trade Receivables0000000032
Cash Equivalents flag ⓘ 00161612343404242
Others Assets ⓘ 0211213432423673341
Total Assets ⓘ 38373837636766768088
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + 1-2010-1-28221-3936-2
PBT ⓘ -0-1112543676
Adjustment ⓘ 1111-22-0-0-0-1-1
Changes in Working Capital ⓘ -0-219-1-2919-0-4432-5
Tax Paid ⓘ 0-0-0-1-1-1-1-1-2-1
Cash Flow From Investing Activity ⓘ + -22061231-1562
Capex -00002600-012
Net Investments -22051-31-1550
Others ⓘ 0000000000
Cash Flow From Financing Activity ⓘ + 0000000000
Net Proceeds from Shares ⓘ 0000000000
Net Proceeds from Borrowing ⓘ 0000000000
Interest Paid ⓘ 0000000000
Dividend Paid ⓘ 0000000000
Others ⓘ 0000000000
Net Cash Flow ⓘ -1-0160-5230-34420
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)-0.57-3.180.821.148.444.441.875.946.745.27
ROCE (%)-0.57-1.472.072.1249.696.053.797.999.126.89
Asset Turnover Ratio00000.45000.010.030
PAT to CFO Conversion(x)N/AN/AN/AN/A-1.177.331-9.757.2-0.5
Working Capital Days
Receivable Days0000000365216.400
Inventory Days00001.2000000
Payable Days0000000019.100

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Transchem Ltd FAQs

The current trading price of Transchem on 14-Aug-2026 16:59 is ₹319.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Aug-2026 the market cap of Transchem stood at ₹390.5 Cr

The latest P/E ratio of Transchem as of 13-Aug-2026 is 58.07.

The latest P/B ratio of Transchem as of 13-Aug-2026 is 4.49.

The 52-week high of Transchem is ₹377.6 and the 52-week low is ₹38.45.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transchem is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transchem Ltd is a below average quality company.

The key valuation ratios of Transchem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Transchem Ltd

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

  • Contract Research Facility.
  • Custom Synthesis of Molecules.
  • Contract Manufacturing of API's as per GMP Guidelines.
  • Intermediates.
  • Veterinary Formulations.
  • Q.A. & Regulatory Support.

Product:

Anthelmintics

  • Albendazole USP / EP /BP
  • Ricobendazole (Albendazole Sulphoxide)
  • Mebendazole EP / BP / USP / POLY 'C'
  • Oxyclozanide BP VET
  • Closantel Sodium EP / BASE
  • Clorsulon USP
  • Nitroscanate
  • Fenbendazole EP/BP/BP VET
  • Oxfendazole BP VET / EP
  • Flubendazole EP / 98%
  • Nitroxynil BP VET
  • Rafoxanide BP VET
  • Triclabendazole
  • Praziquantel BP / USP

Veterinary API's

  • Diminazene Diaceturate B VET C
  • Quinapyramine Salts B VET C
  • Parvaquone
  • Toldimfos Sodium
  • Acepromazine Maleate BP VET
  • Butaphosphan
  • Flunixin Meglumine USP
  • Homidium Bromide / Chloride
  • Isometamedium

Ectoparaciticides

  • Cyromazine.
  • Cymiazole
  • S-Methoprene
  • Azamethiphos.

Human Use API's

  • Ramipril EP
  • Frusemide EP / BP / USP
  • Gabapentin USP
  • Cetirizine DI HCL EP/BP
  • Lamotrigine
  • Pentamidine Isetionate BP
  • Succinylcholine Chloride USP
  • Epinastine HCL
  • Nifuroxazide
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Address : The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: